CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Acupuncture auricular

Randomized controlled study on ear-electroacupuncture treatment of endometriosis-induced dysmenorrhea in patients

Written by CYBERMED LIFE NEWS
facebook Share on Facebook
Abstract Title:

[Randomized controlled study on ear-electroacupuncture treatment of endometriosis-induced dysmenorrhea in patients].

Abstract Source:

Free Radic Res. 2008 Jan;42(1):94-102. PMID: 19761114

Abstract Author(s):

Ya-bei Jin, Zhan-ling Sun, Hui-fang Jin

Article Affiliation:

Department of Acu-moxibustion, Zhejiang Hospital of Integrated Chinese and Western Medicine, Hangzhou 310003, China. This email address is being protected from spambots. You need JavaScript enabled to view it.

Abstract:

OBJECTIVE: To observe the therapeutic effect of ear-electroacupuncture (Ear-EA) on dysmenorrhea in patients with endometriosis and to explore its underlying mechanism.

METHODS: A total of 80 endometriosis patients were randomly and equally divided into ear-EA group and body-EA group. EA (50 Hz, 0.5-0.8 mA) was applied to auricular points (Uterus, Subcortex, Shenmen, Endocrine, etc.) and body acupoints [Tianshu (ST 25), Qihai (CV 6), Guanyuan (CV 4), Sanyinjiao (SP 6), Diji (SP 8), Uterus (EX-CA 1), etc.] respectively for 30 min, once every other day for 3 months. Dysmenorrhea severity score (DSS) was assessed and plasma prostaglandin (PGE2) and 6-Keto-PGF1alpha levels detected by radioimmunoassay.

RESULTS: Compared with pre-treatment, DSS lowered significantly during the 1st and 2nd menstrual cycle in body-EA group, and during the 1st, 2nd and 3rd menstruation in ear-EA group; and the DSS of ear-EA group during the 3rd menstruation was evidently lower than that of body-EA group (P<0.05). During the 3rd menstrual onset after the treatment, plasma PGE2 contents in both groups decreased obviously (P<0.01), and plasma 6-Keto-PGF1alpha, levels increased considerably in comparison with pre-treatment (P<0.01). Comparison between two groups during the 3rd menstruation showed that plasma PGE2 level of ear-EA group was markedly lower than that of body-EA group, and 6-Keto-PGF1alpha, level of ear-EA group was significantly higher than that of body-EA group (P<0.05). No significant difference was found between two groups in clinical therapeutic effect (P>0.05).

CONCLUSION: Both ear-EA and body-EA can effectively relieve endometriosis-induced dysmenorrhea, and the former is superior to the later in reducing pain severity, which may be closely related to their effects in reducing plasma PGE2 and raising 6-Keto-PGF1alpha level.


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.